← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2011First marketed drug
Jul 24, 2020First NDA
Jul 24, 2020Last known activity
Jul 24, 2020
Timeline
2000s
- Jun 1, 2001
Hatchtech Pty Ltd— Founded
2020s
- Jul 24, 2020
abametapir— Marketing Organization
- Jul 24, 2020
abametapir— NDA Organization
- Jul 24, 2020
abametapir— NDA Secondary Org
Drugs by trial phase (4 distinct, 9 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (9)
- NCT02097485Lead sponsorPhase 2May 1, 2014
- NCT02062060Lead sponsorPhase 3Feb 1, 2014
- NCT02060903Lead sponsorPhase 3Feb 1, 2014
- NCT02062073Lead sponsorPhase 1Jan 1, 2014
- NCT02061813Lead sponsorPhase 1Jan 1, 2014
- NCT02010333Lead sponsorPhase 2Apr 1, 2013
- NCT01907490Lead sponsorPhase 2Mar 1, 2013
- NCT01518699Lead sponsorPhase 1Jan 1, 2012
- NCT01336647Lead sponsorPhase 2Apr 1, 2011
Details
- Founded
- Melbourne, AU Jun 1, 2001
- First NDA
- Jul 24, 2020
- Last known activity
- Jul 24, 2020